| HOME >> MEDICINE >> TECHNOLOGY |
TABLE 74 R&D EXPENDITURE, 2008 – 2009
TABLE 75 ELAN'S PIPELINE DRUGS
TABLE 76 BIOVAIL'S PIPELINE DRUGS
TABLE 77 ALKERMES'S PIPELINE DRUGS
TABLE 78 NEKTAR'S PIPELINE DRUGS
TABLE 79 SKYE PHARMA'S PIPELINE DRUGS
TABLE 80 TOP COMPANIES & THEIR STRATEGIES
TABLE 81 BECTON DICKINSON – TOTAL REVENUES, BY SEGMENT ($MILLION)
TABLE 82 BAXTER BIOPHARMA REVENUES, BY SEGMENT
TABLE 83 YPSOMED - TOTAL REVENUES, BY SEGMENT ($MILLION)
TABLE 84 TOP 10 DRUG DELIVERY TECHNOLOGIES MARKET, BY REGION, 2008 – 2015
TABLE 85 NORTH AMERICAN TOP 10 DRUG DELIVERY TECHNOLOGIES MARKET, BY SEGMENT
TABLE 86 EUROPEAN TOP 10 DRUG DELIVERY TECHNOLOGIES MARKET, BY SEGMENT
TABLE 87 ASIAN TOP 10 DRUG DELIVERY TECHNOLOGIES
TABLE 88 REST OF THE WORLD TOP 10 DRUG DELIVERY TECHNOLOGIES MARKET
TABLE 89 MULTIPLE SCLEROSIS PREVALENCE, BY GEOGRAPHY, 2009
TABLE 90 OSTEOPOROSIS PREVALENCE, BY GEOGRAPHY, 2009
TABLE 91 DIABETES PREVALENCE, BY GEOGRAPHY, 2009
TABLE 92 CANCER PREVALENCE, BY GEOGRAPHY, (2009)
TABLE 93 RHEUMATOID ARTHRITIS PREVALENCE, BY GEOGRAPHY, (2009)
TABLE 94 ANEMIA PREVALENCE, BY GEOGRAPHY, 2009
TABLE 95 HEPATITIS-C PREVALENCE, BY GEOGRAPHY, 2009
TABLE 96 CROHN'S DISEASE PREVALENCE, BY GEOGRAPHY, 2009
TABLE 97 PSORIASIS PREVALENCE, BY GEOGRAPHY, 2009
TABLE 98 TOTAL REVENUES & R&D EXPENDITURE
TABLE 99 TOTAL REVENUES, BY GEOGRAPHY
TABLE 100 TOTAL REVENUES, 2006 – 2010
TABLE 101 SEGMENT SPECIFIC REVENUES ($MILLION)
TABLE 102 TOTAL REVENUES & R&D EXPENDITURE ($MILLION)
TABLE 103 TOTAL REVENUES, BY GEOGRAPHY
TABLE 104 REVENUES, BY SEGMENTS
TABLE 105 TOTAL REVENUES & NET INCOME ($MILLION)
TABLE 106 TOTAL REVENUES, 2007 – 2009
TABLE 107 BAXTER BIOPHARMA – TOTAL REVENUES & R&D EXPENSES ($MILLION)
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |